Liu Y - Search Results

1

LHPP inhibits hepatocellular carcinoma cell growth and metastasis.

Liao L, Duan D, Liu Y, Chen L. Liao L, et al. Among authors: liu y. Cell Cycle. 2020 Jul;19(14):1846-1854. doi: 10.1080/15384101.2020.1783472. Epub 2020 Jun 24. Cell Cycle. 2020. PMID: 32578511 Free PMC article.

2

Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response.

Zhang Y, Liu Y, Duan J, Wang H, Zhang Y, Qiao K, Wang J. Zhang Y, et al. Among authors: liu y. Cell Cycle. 2019 Dec;18(23):3337-3350. doi: 10.1080/15384101.2019.1676581. Epub 2019 Oct 10. Cell Cycle. 2019. PMID: 31599189 Free PMC article.

3

TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.

Liu Y, Tao S, Liao L, Li Y, Li H, Li Z, Lin L, Wan X, Yang X, Chen L. Liu Y, et al. Nat Commun. 2020 Jan 17;11(1):348. doi: 10.1038/s41467-019-14190-2. Nat Commun. 2020. PMID: 31953436 Free PMC article.

4

Proscillaridin A slows the prostate cancer progression through triggering the activation of endoplasmic reticulum stress.

Wang F, Liu L, Tong Y, Li L, Liu Y, Gao WQ. Wang F, et al. Among authors: liu y, liu l. Cell Cycle. 2020 Mar;19(5):541-550. doi: 10.1080/15384101.2020.1716484. Epub 2020 Feb 2. Cell Cycle. 2020. PMID: 32009541 Free PMC article.

5

Proscillaridin A inhibits hepatocellular carcinoma progression through inducing mitochondrial damage and autophagy.

Luo M, Liu Y, Liu N, Shao W, Ming L, Liu J, Xie Y. Luo M, et al. Among authors: liu j, liu y, liu n. Acta Biochim Biophys Sin (Shanghai). 2021 Jan 12;53(1):19-28. doi: 10.1093/abbs/gmaa139. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 33201987 Free article.

6

Inhibition of AMPK activity by TRIM11 facilitates cell survival of hepatocellular carcinoma under metabolic stress.

Liu Y, Xu Y, Wang F, Tong Y, Li H, Wan X, Yang X, Chen L. Liu Y, et al. Clin Transl Med. 2021 Dec;11(12):e617. doi: 10.1002/ctm2.617. Clin Transl Med. 2021. PMID: 34919347 Free PMC article. No abstract available.

7

PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.

Liu Y, Zhang JB, Qin Y, Wang W, Wei L, Teng Y, Guo L, Zhang B, Lin Z, Liu J, Ren ZG, Ye QH, Xie Y. Liu Y, et al. Among authors: liu j. Hepatology. 2013 Aug;58(2):692-705. doi: 10.1002/hep.26398. Hepatology. 2013. PMID: 23505027

8

Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma.

Lv T, Liu Y, Zhang J, Xu L, Zhu Y, Yin H, An H, Lin Z, Xie Y, Chen L. Lv T, et al. Among authors: liu y. PLoS One. 2014 May 5;9(5):e95996. doi: 10.1371/journal.pone.0095996. eCollection 2014. PLoS One. 2014. PMID: 24797520 Free PMC article. Clinical Trial.

9

MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway.

Lin ZH, Wang L, Zhang JB, Liu Y, Li XQ, Guo L, Zhang B, Zhu WW, Ye QH. Lin ZH, et al. Among authors: liu y. Int J Oncol. 2014 Aug;45(2):629-40. doi: 10.3892/ijo.2014.2455. Epub 2014 May 22. Int J Oncol. 2014. PMID: 24859810

10

Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21(Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway.

Zhang Y, Liu Y, Duan J, Yan H, Zhang J, Zhang H, Fan Q, Luo F, Yan G, Qiao K, Liu J. Zhang Y, et al. Among authors: liu j, liu y. Hepatology. 2016 Mar;63(3):880-97. doi: 10.1002/hep.28395. Epub 2016 Feb 3. Hepatology. 2016. PMID: 26659654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,791 results

Search Page

Filters